Pfizer’s Rezulin Suit: Prosecuted by Thomas Girardi, Defended by Pierce O’Donnell — While Concurrently Both Girardi and O’Donnell Were Representing Plaintiffs in Class-Action Against Sempra
After just two days of deliberations, a Los Angeles jury unanimously rejected claims Thursday that the diabetes drug Rezulin — taken off the market in March 2000 because of safety concerns — contributed to the deaths or illness of three people.
In the Los Angeles case, the jury found that the plaintiffs’ attorney, Thomas Girardi, proved that Rezulin can cause liver injury, but failed to “prove that Rezulin was a substantial factor in” the deaths of Lupe Contreras and Manuel Cervantes, or the illness of Leonard Clinkenbeard.
Los Angeles County Superior Court Judge Carl J. West presided over the seven-week trial. Attorney Pierce O’Donnell, who defended the drug company, could not be reached for comment.
Please see @: